Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alina, Hartmann"'
Autor:
Franziska Darzentas, Monika Szczepanowski, Michaela Kotrová, Alina Hartmann, Thomas Beder, Nicola Gökbuget, Stefan Schwartz, Lorenz Bastian, Claudia Dorothea Baldus, Karol Pál, Nikos Darzentas, Monika Brüggemann
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe malignant transformation leading to a maturation arrest in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) occurs early in B-cell development, in a pro-B or pre-B cell, when somatic recombination of variable (V), diversity (D)
Externí odkaz:
https://doaj.org/article/13211689f07d4864a94f776d95537531
Autor:
Franziska Darzentas, Monika Szczepanowski, Michaela Kotrová, Miriam Kelm, Alina Hartmann, Thomas Beder, Nicola Gökbuget, Martin Neumann, Lorenz Bastian, Claudia D. Baldus, Karol Pál, Nikos Darzentas, Monika Brüggemann
Publikováno v:
HemaSphere, Vol 7, Iss 1, p e820 (2023)
Externí odkaz:
https://doaj.org/article/1622b9822a764aafa48654313ad47743
Autor:
Maren Reimer, Julia Forstenpointner, Alina Hartmann, Jan Carl Otto, Jan Vollert, Janne Gierthmühlen, Thomas Klein, Philipp Hüllemann, Ralf Baron
Publikováno v:
PAIN Reports, Vol 5, Iss 3, p e820 (2020)
Abstract. Introduction:. Stratification of patients according to the individual sensory phenotype has been suggested a promising method to identify responders for pain treatment. However, many state-of-the-art sensory testing procedures are expensive
Externí odkaz:
https://doaj.org/article/b43f848bba35492bb3b074048b145175
Autor:
Franziska, Darzentas, Monika, Szczepanowski, Michaela, Kotrová, Miriam, Kelm, Alina, Hartmann, Thomas, Beder, Nicola, Gökbuget, Martin, Neumann, Lorenz, Bastian, Claudia D, Baldus, Karol, Pál, Nikos, Darzentas, Monika, Brüggemann
Publikováno v:
HemaSphere. 7(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3fc2bac44c071df6a67d2047fa5cdbbf
https://pubmed.ncbi.nlm.nih.gov/36570692
https://pubmed.ncbi.nlm.nih.gov/36570692
Autor:
Sophie Steinhäuser, Patricia Silva, Lennart Lenk, Thomas Beder, Alina Hartmann, Sonja Hänzelmann, Lars Fransecky, Martin Neumann, Lorenz Bastian, Simone Lipinski, Kathrin Richter, Miriam Bultmann, Emely Hübner, Shuli Xia, Christoph Röllig, Fotini Vogiatzi, Denis Martin Schewe, Veronica Yumiceba, Kristin Schultz, Malte Spielmann, Claudia Dorothea Baldus
Publikováno v:
Leukemia.
Acute myeloid leukemia (AML) is characterized by complex molecular alterations and driver mutations. Elderly patients show increased frequencies of IDH mutations with high chemoresistance and relapse rates despite recent therapeutic advances. Besides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8f5e9cc0e351020800467458f39a027
https://pubmed.ncbi.nlm.nih.gov/36411356
https://pubmed.ncbi.nlm.nih.gov/36411356
Autor:
Andreas Viardot, Monika Brüggemann, Nicola Goekbuget, Thomas Burmeister, Mustafa Kondakci, Sören Franzenburg, Max S. Topp, Christoph Faul, Andre Franke, Stefan Schwartz, Folker Schneller, Claudia D. Baldus, Sonja Hänzelmann, Heiko Trautmann, Walter Fiedler, Martin Neumann, Alina Hartmann, Lorenz Bastian
Publikováno v:
Blood. 136:11-12
Targeted interventions and new risk stratification approaches for the improvement of outcomes in B cell precursor acute lymphoblastic leukemia (BCP-ALL) require an understanding of high-risk driver subtypes, their clinical phenotypes and actionable t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e064df029235947308f90ab96956f96c
https://doi.org/10.1182/blood-2020-143032
https://doi.org/10.1182/blood-2020-143032
Autor:
Nael Alakel, Folker Schneller, Jutta Ortiz Tanchez, Heiko Trautmann, Carsten Müller-Tidow, Martin Neumann, Cornelia Schlee, Lorenz Bastian, Mustafa Kondakci, Michael P Schroeder, Walter Fiedler, Nicola Goekbuget, Stefan Schwartz, A. Reichle, Philipp A. Greif, Sonja Hänzelmann, Monika Brüggemann, Lars Fransecky, Thomas Burmeister, Michael Starck, Alina Hartmann, Sebastian Vosberg, Claudia D. Baldus
Publikováno v:
Blood. 136:37-38
Introduction: In T-ALL, in contrast to BCP-ALL, molecular subgroups are less well defined. Molecular subgroups are based on aberrant expression of oncogenes often resting upon structural aberrations (chromosomal translocation, copy number variations,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fa1461a7f664f43937aee3811d2b1c5
https://doi.org/10.1182/blood-2020-141921
https://doi.org/10.1182/blood-2020-141921